BIOA vs KYTX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 19, 2026

BIOA

58.2
AI Score
VS
BIOA Wins

KYTX

36.4
AI Score

Investment Advisor Scores

BIOA

58score
Recommendation
HOLD

KYTX

36score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BIOA KYTX Winner
Net Income -80.61M -78.05M KYTX
Operating Income -92.78M -80.92M KYTX
ROE -29.6% -47.1% BIOA
ROA -27.3% -35.5% BIOA
Total Assets 294.89M 219.82M BIOA
Cash 188.89M 31.81M BIOA
Current Ratio 14.24 9.06 BIOA
Free Cash Flow -82.35M -82.20M KYTX

Relative Price Performance (Last 90 Days)

BIOA 1M: -56.7% · 3M: -43.4% KYTX 1M: +15.5% · 3M: -5.4%

Current Technical Phase

BIOA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.4%), weak momentum, RSI 30

RSI (14): 29.8 · Price: $9.48

KYTX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 53.6 · Price: $8.42

Fundamentals Snapshot

Metric BIOA KYTX
Market Cap
Forward P/E -4.0 -2.7
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin -7.5%
Operating Margin -12.0% 0.0%
EPS -2.15 -2.68
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BIOA is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.